期刊文献+

隐球菌致病的免疫学机制研究进展 被引量:5

Research Progress in Immunological Mechanisms of Cryptococcus
下载PDF
导出
摘要 感染隐球菌是否致病主要取决于病菌的毒力及机体免疫防御能力。机体免疫功能低下或缺陷易感染新型隐球菌,而格特隐球菌易感染免疫功能正常的宿主。一方面,宿主免疫细胞可通过复杂的免疫防御机制杀灭入侵的隐球菌;另一方面,隐球菌可通过多种策略逃避机体宿主细胞的清除作用(免疫逃逸)。本综述主要阐述隐球菌的致病过程和机体防御隐球菌感染的免疫学机制。 Whether infection of Cryptococcus causes disease in host or not depends on the virulence of the pathogen and the immune defense ability of the host. Cryptococcus neoformans(C. neoformans)mainly causes opportunistic infections in the immunocompromised or immunodeficient patients. In contrast, Cryptococcus gattii(C. gattii)mainly attacks the immunocompetent individuals. On the one hand, the host immune cells can eliminate the invasive Cryptococcus through a complex immune mechanism;on the other hand, Cryptococcus can evade the clearance of host immune cells by adopting various strategies(immune escape). This review mainly focuses on the pathogenic mechanism of Cryptococcus, and the host's immune defense mechanism against cryptococcal infection.
作者 宋英 邱玉芳 刘惟优 袁小亮 SONG Ying;QIU Yu-fang;LIU Wei-you;YUAN Xiao-liang(Gannan Medical University The Grade 2016, Ganzhou, Jiangxi 341000;Gannan Medical University Department of Respiratory Medicine, The Fisrst Affiliated Hospital, Ganzhou, Jiangxi 341000)
出处 《赣南医学院学报》 2019年第4期417-421,共5页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金 江西省卫生计划生育委员会科技计划项目(编号:20141114)
关键词 隐球菌 免疫机制 巨噬细胞 树突状细胞 Cryptococcus Immune mechanism Macrophage Dendritic cells
  • 相关文献

参考文献3

二级参考文献12

  • 1Chiapello L,Iribarren P,Cervi L,et al.Mechanisms for induction of immunosuppression during experimental cryptococcosis: role of glucuronoxylomannan[J].Clin Immunol,2001, 100(1):96-106.
  • 2Mariano Andrade R, Monteiro Almeida G, Alexandre DosReis G,et al.Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses[J]. Cell Immunol,2003,222(2): 116-125.
  • 3Cherniak R,Morris LC,Anderson BC,et al.Facilitated isolation,purification,and analysis of glucuronoxylomannan of Cryptococcus neoformans [J].Infect Immun,1991,59(1):59-64.
  • 4Wozniak KL, Levitz SM. Isolation and purification of antigenic components of Cryptococcus [J]. Methods Mol Biol,2009,470(2):71-83.
  • 5Villena SN, Pinheiro RO, Pinheiro CS,et al.Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand[J].Cell Microbiol,2008,10(6):1274-1285.
  • 6Ellerbroek PM, Walenkamp AM,Hoepelman AI,et al. Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators[J]. Current Medical Chemistry,2004,11(2):253-266.
  • 7Monari C, Retini C, Casadevall A,et al. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils[J]. European Journal of Immunology,2003,33(4):1041-1051.
  • 8Chaka W,Verheul AF,Vaishnav VV,et al. Cryptococcus neoformans and cryptococcal glucuronoxylomannan,galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells[J].Infect Immun,1997,65(1):272-278.
  • 9Otter M,Zockova P,Kuiper J,et al.Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tisue-type plasminogen activator[J]. Hepatology,1992,16(1):54-59.
  • 10Syme RM, Spurrell JC, Amankwah EK,et al. Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes[J].Infect Immun,2002,70(11):5972-5981.

共引文献9

同被引文献44

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部